Mark Freitas is a Managing Director and Life Sciences Market Lead with Alvarez and Marsal Healthcare’s industry group in Boston. With over two decades of expertise, Freitas specializes in helping businesses reach their full potential by developing successful strategies that maximize growth while avoiding operational challenges. His expertise spans corporate finance and operations, strategic planning, board governance, mergers and acquisitions activity, risk management, and compliance.
Prior to joining A&M, Freitas served as the Global Lead of Growth and Corporate Strategy in Life Sciences for Accenture. He was also the Co-Founder of a boutique strategy consulting firm, Axia Ltd., which Accenture acquired in 2015. After the acquisition, Freitas joined Accenture Strategy and helped build the world’s fourth largest strategy consulting practice. Before that, Earlier in his career, Freitas worked as a microbiologist, a food and drug lawyer, and Head of Corporate Strategy for ARIAD Pharmaceuticals, now part of Takeda. Freitas holds a bachelor’s degree from the University of Connecticut and a JD from Tulane University.
